%0 Journal Article
%T Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
%A Feng Xie
%A Graeme Ball
%A Jean-Eric Tarride
%J Archive of "PharmacoEconomics Open".
%D 2018
%R 10.1007/s41669-017-0030-7
%X The online version of this article (doi:10.1007/s41669-017-0030-7) contains supplementary material, which is available to authorized users
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820234/